Toro Neurovascular
About Toro Neurovascular
Toro Neurovascular develops proprietary catheter technologies designed for thrombectomy procedures in ischemic stroke treatment, enabling efficient navigation through complex cerebral vasculature. Their Toro 88 Superbore Catheter enhances clot removal capabilities, improving patient outcomes by empowering physicians to treat a higher volume of patients effectively.
```xml <problem> Ischemic stroke, caused by blood clots obstructing arteries in the brain, is a leading cause of disability worldwide and poses a significant burden on healthcare systems. Current thrombectomy procedures can be limited by challenges in navigating the complex cerebral vasculature, potentially impacting the efficiency of clot removal and overall patient outcomes. </problem> <solution> Toro Neurovascular develops advanced catheter technologies designed to improve the efficiency and effectiveness of thrombectomy procedures for ischemic stroke. Their Superbore Catheters are engineered to navigate challenging distal vasculature, enabling physicians to access and remove clots more effectively. The catheters' design aims to simplify the procedure, empowering physicians to treat a higher volume of patients and improve access to care globally. The company focuses on providing reliable tools that can enhance clot ingestion and improve patient outcomes in stroke treatment. </solution> <features> - Superbore Catheter designed to track to the MCA over a microcatheter. - MicroFlex Technology for efficient tracking to the M1. - Distal Glide Zone for conforming in tortuosity. - Vessel-matched aspiration to empower complete clot ingestion. - Engineered for reliability, empowering physicians of all skill levels. </features> <target_audience> The primary target audience includes physicians, hospitals, and healthcare systems involved in stroke treatment, particularly those specializing in neurovascular procedures and thrombectomy. </target_audience> ```
What does Toro Neurovascular do?
Toro Neurovascular develops proprietary catheter technologies designed for thrombectomy procedures in ischemic stroke treatment, enabling efficient navigation through complex cerebral vasculature. Their Toro 88 Superbore Catheter enhances clot removal capabilities, improving patient outcomes by empowering physicians to treat a higher volume of patients effectively.
Where is Toro Neurovascular located?
Toro Neurovascular is based in Irvine, United States.
When was Toro Neurovascular founded?
Toro Neurovascular was founded in 2023.
How much funding has Toro Neurovascular raised?
Toro Neurovascular has raised 3020000.
Who founded Toro Neurovascular?
Toro Neurovascular was founded by Ryan Walker and Hyung Posalit.
- Ryan Walker - Co-Founder/COO
- Hyung Posalit - Founder/CEO
- Location
- Irvine, United States
- Founded
- 2023
- Funding
- 3020000
- Employees
- 6 employees